The R&D budget in Health and Medical Sciences in Mexico showed an overall increasing trend from 2012 to 2023, with significant fluctuations. The actual value in 2023 stood at 6.88 Unit of Total GBARD. The year-on-year variations reveal a mixture of growth and declines, with notable growth in years such as 2016 (13.34%) and contractions such as in 2014 (-11.82%). Over recent years, a trend toward stabilization is observed with modest increases around 0.3% to 0.57%. The last 5-year CAGR up to 2023 is 1.53%, indicating a steady but slow growth. Future forecasts suggest a slight increase with a 5-year CAGR to 2027 anticipated at 0.43%.
Future trends to watch for include innovations in pharmaceuticals, biotechnology, and digital health solutions. Sustainable R&D funding strategies, collaborations with international research entities, and government policy changes will also play crucial roles in shaping the budget trajectory.
